Institutional Ownership Sellas Life Sciences Group, Inc. (SLS)
This table provides information about the institutional ownership of Sellas Life Sciences Group, Inc. (SLS). We have compiled data on the 38 institutions that hold shares in the stock, with a total of 7.08 Million shares, which have been reported (via 13F filing form) to have a value of $7.94 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
R Squared LTD
Central, K3 |
Jan 22, 2025 Q4 2024 |
2,197
shares
|
$2,592
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Feb 07, 2025 Q4 2024 |
1,660
shares
|
$1,958
0.0% of portfolio
|
Q4 2023
Reduced 50.0%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
572
shares
|
$674
0.0% of portfolio
|
Q4 2024
Added 8.75%
|
|
|
Jones Financial Companies Lllp
|
Feb 05, 2025 Q4 2024 |
374
shares
|
$441
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
200
shares
|
$236
0.0% of portfolio
|
Q3 2024
Reduced 70.1%
|
|
|
Janiczek Wealth Management, LLC
|
Jul 25, 2024 Q2 2024 |
11
shares
|
$12
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Parkside Financial Bank & Trust
|
Feb 05, 2025 Q4 2024 |
2
shares
|
$2
0.0% of portfolio
|
Q2 2022
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|